Edwards Paul J
Boehringer Ingelheim (Canada) Ltd, Research & Development, 2100 rue Cunard, Laval, QC, H7S2G5, Canada.
Curr Opin Drug Discov Devel. 2009 Nov;12(6):899-914.
This article describes the use of parallel chemistry techniques for drug discovery, based on publications from January 2006 to December 2008. Chemical libraries that yielded active compounds across a range of biological targets are presented, together with synthetic details when appropriate. Background information for the biological targets involved and any SAR that could be discerned within members of a library series also is discussed. New technological developments, as applied to library design and synthesis and, more generally, in the discovery of biologically active entities, are highlighted. In addition, the likely future directions for parallel chemistry in its ability to impact upon drug discovery are also presented.
本文基于2006年1月至2008年12月的出版物,描述了平行化学技术在药物发现中的应用。展示了在一系列生物靶点上产生活性化合物的化学文库,并在适当的时候给出了合成细节。还讨论了所涉及生物靶点的背景信息以及在文库系列成员中可识别的任何构效关系。重点介绍了应用于文库设计与合成以及更广泛地应用于生物活性实体发现的新技术发展。此外,还介绍了平行化学在影响药物发现能力方面可能的未来发展方向。
Curr Opin Drug Discov Devel. 2009-11
Curr Opin Drug Discov Devel. 2006-7
Curr Opin Drug Discov Devel. 2002-7
Methods Mol Biol. 2011
Curr Opin Drug Discov Devel. 2004-5
Org Biomol Chem. 2008-4-7
Curr Opin Drug Discov Devel. 2005-5
Anticancer Drug Des. 1997-4
Curr Opin Drug Discov Devel. 2004-5
Curr Opin Drug Discov Devel. 2003-5